Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Burkitt Lymphoma 30Lymphoma 28Lymphoma, Non-Hodgkin 27Lymphoma, Mantle-Cell 27Lymphoma, Large-Cell, Immunoblastic 27Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Follicular 27Recurrence 26Lymphoma, B-Cell, Marginal Zone 26Leukemia, Lymphocytic, Chronic, B-Cell 26Leukemia 24Hodgkin Disease 23Myelodysplastic Syndromes 22Leukemia, Myeloid, Acute 22Leukemia, Myeloid, Chronic-Phase 20Leukemia, Myeloid, Accelerated Phase 19Blast Crisis 19Multiple Myeloma 18Congenital Abnormalities 18Neoplasms, Plasma Cell 17Myeloproliferative Disorders 16Leukemia, Myelomonocytic, Chronic 16Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 14Lymphoma, T-Cell, Cutaneous 13Waldenstrom Macroglobulinemia 12Sarcoma 12Myelodysplastic-Myeloproliferative Diseases 12Anemia, Refractory, with Excess of Blasts 12

Interventions

Topotecan 2trioctyl phosphine oxide 1omburtamab I-131 1Melphalan 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Carcinomatosis × Busulfan × Sarcoma × Clear all
NCT00006246 2009-10-07

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Pediatric Brain Tumor Consortium

Phase 1 Completed
28 enrolled
CNSLymphoidOther hematologic neoplasmOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Leukemia, Lymphoma, Medulloblastoma, Neoplasm Metastasis, Oligodendroglioma, Recurrence, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡